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The rapid spread of the coronavirus disease 2019 (COVID-19) has led to the development of therapeutic
inhibitor drug of SARS-CoV-2, which can inhibit the viral enzyme RNA-dependent-RNA-polymerase
(RdRp), thereby preventing the replication, transcription, and synthesis of RNA virus in the host cells.
Previous in-vitro studies revealed that Andrographis paniculata has the potential to inhibit the virus.
Therefore, this study aims to isolate the specific compounds of Andrographis paniculata, which play a
role in inhibiting SARS-CoV-2 RdRp using molecular docking. A total of 19 compounds were identified
in previous literature studies, while remdesivir and favipiravir were used as the positive control. All
compounds and proteins were applied to minimize and optimize energy. Furthermore, the docking
method was carried out using Autodock 4.2.6 software with a specific grid box containing the active site
of RdRp (ID: 6M71), and the Lamarckian Genetic Algorithm was used to determine the conformation.
The best docking was screened on ADMET prediction and the binding energy was evaluated. There are
18 compounds of Andrographis paniculata including the top three, namely andrographolactone (∆G
= -8.86 kcal/mol), andrographolide (∆G = -7.74 kcal/mol), and andrographidine-A (∆G = -7.68 kcal/
mol), which showed the strongest binding affinity to the SARS-CoV-2 RdRp protein compared to other
compounds and the positive control remdesivir (∆G = -5.73 kcal/mol) and favipiravir (∆G = -5.20 kcal/
mol). Furthermore, active amino acids play a role in this interaction by forming strong hydrogen bonds,
such as TYR 619, LYS 621, ASP 760, and ASP 623. Andrographolactone has the highest potential as
SARS-CoV-2 RdRp inhibitor, hence, it can be used as a novel therapeutic candidate.
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INTRODUCTION
A new pandemic known as Corona Virus Disease 2019
(COVID-19) was first reported in December 2019
in Wuhan, China, and caused by the Severe Acute
Respiratory Syndrome Corona Virus-2 (SARS-CoV-2)
(Gorbalenya, et al., 2020). Furthermore, the disease is
spreading rapidly around the world with millions of
victims, and it also has a major social and economic
impact (da Silva, et al., 2020; Nimgampalle, et al.,
2021). To overcome the infection and viral replication,
it is important to understand the proteins involved
in the process. The viral spike protein binds to the
human receptor within a metallopeptidase, namely
Angiotensin-Converting Enzyme 2 (ACE2) (Borse,
et al., 2021; Dong, et al., 2020). After the virus enters
the host cell, its positive genomic RNA attaches to the
ribosome to translate two large terminal polyproteins,
which are processed by proteolysis into components for
packaging new virions. The 3CLpro and PLpro provide
components for packaging new virions of enormous
viral polyproteins translated on the host ribosomes,
after which RNA-dependent-RNA-polymerase (RdRp)
replicates the SARS-CoV-2 RNA genome (Morse, et al.,
2020).

Previous studies revealed that RdRp plays a vital
role in SARS-CoV-2 replication as a potential drug
target (Lung et al., 2020; Parvez et al., 2020). It has
also been highlighted as a fundamental target in
computational strategies, such as molecular docking
due to its importance in the viral replication stage.
Molecular docking is a robust, rational, and inexpensive
method, which provides an understanding of how the
critical NSP interacts with ligands at the active site.
Therefore, it supports the design and screening of
novel antiviral agents against COVID-19 (Wu, et al.,
2020; Yu, et al., 2020). Another literature predicted the
binding of andrographolide and its derivatives to RdRp
using molecular docking and simulation, and the results
showed that the analogs oxo-andrographolide have strong
binding energy compared to andrographolide (Sharma et
al., 2020). Neoandrographolide (AGP3) had significant
binding to the catalytic site of RdRp, thereby inhibiting
the target therapeutically (Murugan et al., 2021).
Herbal medicines play an important role in the control
and prevention of infectious diseases (Kwon, et al.,
2019). Several clinical studies revealed that they have
beneficial effects in treating and preventing epidemic
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diseases, such as the SARS Coronavirus (SARS-CoV)
(Yang, et al., 2020). COVID-19, caused by SARSCoV-2, is a new type of coronavirus, which has 80%
similarity to SARS-CoV and belongs to the Sarbecovirus
subgenus of the Betacoronavirus genus (J. F.-W. Chan
et al., 2020; Lipsitch et al., 2020; Lung et al., 2020;
Wrapp et al., 2020). Due to these similarities, several
studies showed that the use of herbal medicines in the
treatment of COVID-19 has a beneficial effect (K. W.
Chan, et al., 2020). Z. Wang & Yang, (2021) revealed
the potential activity of Chinese Herbal Medicine
against SARS-CoV-2 in China Clinical Trial, including
Herba andrographiti (Xiyanping Injection), Sophora
flavescens Ait. (Matrine-sodium chloride injection) and
diammonium glycyrrhizinate enteric-coated capsules. In
China’s experience of fighting the COVID-19 pandemic,
the Chinese Herbal Medicine (CHM) therapy schedule
was included in the treatment guidelines because it has
played an indispensable role (Du, et al., 2021).
Sambiloto (Andrographis paniculata) also known as the
“King of Bitters”, belongs to the Acanthaceae family,
and has been used for centuries in Asia for medicine. In
the official book of Indonesian medicinal plants, bitter
herbs are used as diuretics and antipyretics agents (Patin
et al., 2018; Ratnani et al., 2012). The in-silico study by
Murugan et al., (2020) reported that several compounds
from A. paniculata have promising binding affinity to
RdRp with proper binding to the catalytic site, which
helps to inhibit the target using SARS-CoV-1 PDB
ID: 6NUR. Thailand declared its pilot project openly
in January 2021 for administering and investigating
the effectiveness of A. paniculata extract in patients
diagnosed with COVID-19 (Lim, et al., 2021). An RCT
study also recommended that the regimen of the extract
therapy, namely oral 60 mg, t.i.d., for five days can
be given to adult patients diagnosed with the disease.
Furthermore, the adverse effects caused by the therapy
are limited and benign (Wanaratna et al., 2021).
Indonesia has several traditional medicinal compounds
that can be used to treat SARS-CoV and SARS-CoV-2,
but the mechanism of their activity and efficiency remains
unclear. Therefore, a comprehensive computational
approach with molecular docking was used to predict
the activity of A. paniculata compounds against RdRp as
one of the mechanisms against SARS-CoV-2 infection.
In Rafi et al., (2020)’s study, the compounds extracted
from the plant were obtained from the presumed results
using LC-MS/MS and classified based on the plant part,
namely stems and leaves using sonication with 70%
ethanol. Principal Component Analysis (PCA) was also
used to separate and classify the compounds in its leaves,
such as andrographanine, 14-deoxyandrographolide,
andrographolactone, dehydroandrograpolide as well
as the stem extracts, including andrographolide,
E-ISSN 2477-0612
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apigenin-7,40-dimethylether, 5-hydroxy-7,8-dimethoxy
flavanone, and andrografidin A by observing values
of the peak area. Andrographolactone was found in A.
paniculata leaves, hence, it can be a target plant part for
the isolation of compounds. A total of 31 metabolites
were identified in the stem and leaf extracts with different
intensities and they were divided into groups of diterpene
lactones, flavonoids, and phenolic acids.
METHODS
Materials
A laptop ASUS ROG GL-552VX with a specification
of CoreTM i7-6700HQ Processor Intel®, 12 Gb RAM,
CPU @2,60 GHz ~ 2,59 GHz, and Microsoft Windows
10 as the operating system was used to perform
molecular docking. The software used in this study
includes Avogadro for ligand energy minimization and
Swiss PDB Viewer for protein optimization. Molecular
docking was carried out using Autodock 4.2.6, after
which Discovery Studio Visualizer and PyMOL were
used for visualizing protein-ligand interactions. The
Lipinski screening and ADMET prediction were carried
out using SCFBio and pkCSM web tools.
Methods
Detailed docking studies are necessary to predict the
candidate SARS-CoV-2 RdRp inhibitor of A. paniculata
compounds, and the schematic molecular docking study
process is presented in Figure 1.
Ligand and Protein Preparation
The crystal structure of SARS-CoV-2 RdRp (ID: 6M71)
was downloaded from the RCSB Protein Data Bank.
The target protein was prepared by removing water
molecules and adding all hydrogen using the Discovery
Studio Visualizer. Its structure was optimized with
the Swiss PDB Viewer software using a GROMOS96
force field, and then saved as a .pdb file. A total of 19
compounds of A. paniculata were generated as ligands
from the previously collected data, while Rafi et al.,
(2020)’s study was used for screening to find potential
anti-SARS-CoV-2. The compounds were downloaded at
PubChem and they passed the Lipinski screening using
the SCFBio webserver. Remdesivir and favipiravir were
used as a positive control, after which hydrogen was
added to all ligands, followed by energy minimization
energy using the MMFF94 force field of Avogadro
software.
Molecular Docking
Molecular docking studies of A. paniculata compounds
and positive control to RdRp (6M71) were carried out
using AutoDock. The protein and ligand were uploaded
to Autodock Tools, and detected torsions, which allow
the rotation of all rotatable bonds were used for the

Discovery of SARS-CoV-2 RNA-dependent-RNA-polymerase (RdRp)

Pharm Sci Res, Vol 9 No 2, 2022

83

Figure 1. Schematic molecular docking study of inhibitor SARS-CoV-2 RdRp
ligands. The Gasteiger partial and Kollman charges were
automatically added to the test compounds. The suitable
grid box on the side of active RdRp (ID:6M71) from
Parvez et al. (2020) was used after evaluating another
study. The semi-flexible docking method is ligand flexibly
setting where protein is still in rigid conformation. The
molecular docking was performed using the Lamarckian
Genetic Algorithm with a population size of 150 people
and a maximum evals number of 2.500.000 for every
100 independent runs. The best pose was evaluated using
the lowest binding energy score (∆G) with inhibition
constant (Ki) value as well as the functional crucial
amino acid, which was detected to have a role in docking
interaction by Discovery Studio Visualizer.
ADMET Prediction
The Absorption, Distribution, Metabolism, Excretion,
and Toxicity (ADMET) filtering can be used to predict
the pharmacological properties, metabolizing system,
and toxicity of oral drug discovery candidate. The
Predicting Small Molecule Pharmacokinetic Properties
Using Graph-Based Signatures (pkCSM) online server
was used to reduce academic costs as well as increase
the potential of a highly accurate prediction. All the
parameters model prediction of ADMET on pkCSM were
obtained from Pires et al. (2015). The 19 compounds that
demonstrated good binding affinity were screened for
ADMET by changing the format PDB into SMILES and
then uploading them to the pkCSM online server.
RESULTS AND DISCUSSION
The viral polymerase RdRp, also known as nsp12,
can be a crucial target for inhibiting the replication,
transcription, and synthesis of RNA virus in host cells
(Gao et al., 2020). RdRp protein can cause a high

mutation rate, thereby leading to the emergence of a new
virus that affects the disease profile, such as escaping
the host immunity or increasing resistance to antiviral
therapeutics (Wabalo et al., 2021). Cheminformatics and
computational drug repurposing are tangible strategies
for developing antiviral SARS-CoV-2 in a shorter period
compared to the new drug development techniques.
Furthermore, several computational drug methods, such
as molecular docking have identified potential drug
inhibitors for SARS-CoV-2 infection. The success of the
docking process was evaluated with the scoring function
of free binding energy (∆G) and the main role of amino
acid interaction. Several in-silico studies of A. paniculata
molecules on RdRp SARS-CoV-2 were carried out using
homologous modelings, such as Srikanth et al., (2021),
which docked andrographolide compounds to the target
protein with autodock and MOE software. Murugan et
al., (2021) used the Molecular docking and Molecular
dynamic (MM-GBSA) approach on five compounds
of A. paniculata, and the best results were obtained in
neoandrographolide (AGP3). Sharma et al., (2020)
showed that oxo-andrographolide had the best binding
to the SARS-CoV-2 RdRp protein (ID: 6M71) through
molecular docking, molecular dynamic (MM-GBSA),
Clustering of conformations, PCA, and drug likeness
properties-ADME prediction. This study’s results are
expected to improve previous findings through more
comprehensive compounds of A. paniculata samples
using a molecular docking study approach.
Lipinski Rules Screening
Lipinski’s rule was used to predict a compound’s
bioavailability or ability to be absorbed and circulated in
the body when administered orally. The results showed
that the 19 compounds of A. paniculata passed the criteria
for Lipinski’s rule, as shown in Supplementary Table S1.
E-ISSN 2477-0612
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Furthermore, 19 compounds surpassed the Log P value
screening, which indicates that the drugs can easily be
absorbed and they have an ideal lipophilicity to pass
through the lipid bilayer of intestine, thereby making
it easy for them to reach the target protein and interact.
The ideal molecular weight given by A. paniculata
compounds indicates that the drug can diffuse through the
cell membrane, thereby increasing its oral bioavailability
in the body. The ligands result was consistent with the
good evaluation results of hydrogen donors, and the
acceptors showed that the compound can quickly be
absorbed due to the presence of weak hydrogen bonds
with cells. Minimal energy is also required for the drugs
to enter the blood vessels. Therefore, the 19 compounds
of A. paniculata can become a safe orally active drug for
humans based on the good absorption and bioavailability
of the predicted Lipinski’s rule.
Validation of Positive Control (Remdesivir and
Favipiravir) as RdRp (6M71) Inhibitor
RdRp protein (ID: 6M71) without a native ligand was
used in this study, hence, the existing antiviral drugs
have highly selective inhibitors for the virus’s RNA
polymerase (Loza-Mejía & Salazar, 2020). Some of
them are still in a clinical trial stage, such as remdesivir
and favipiravir, which were used as a positive control for
native ligand alternatives. They also served as inhibitors
in Gao et al. (2020)’s studies about RdRp 6M71 protein,
hence, the analysis of remdesivir amino acid interaction
is very crucial for docking active sites.

Ahsana, et al.

The grid box size preferences in some previous studies
(Borse et al., 2021; da Silva et al., 2020; Nimgampalle et
al., 2021; Parvez et al., 2020) that use the same protein
code 6M71 with remdesivir as a positive control of
docking were tested. These studies referred to Gao et al.
(2020) of 6M71 polymerase RdRp, which had a complex
structure of nsp12 (RdRp) with its cofactors, namely nsp7
and nsp8. These two cofactors can catalyze the synthesis
of viral RNA, which plays a central role in the replication
and transcription cycle of COVID-19 virus. This protein
has three subdomains that are close to the active site.
Furthermore, its active site in motif A contains residues
611 to 626, which have a classic divalent-cation–
binding residue, while motif C consists of 753 to 767,
including catalytic 759 to 761 (Gao et al., 2020). The
catalytic residues are important for the Enzyme-Inhibitor
complex’s stability and viral replication (Sharbidre et al.,
2021).
The best grid box containing an active site of 6M71
with the lowest energy binding score of remdesivir was
obtained from Parvez et al. (2020). The grid box size
was X = 80, Y = 94, Z = 94, and can accommodate the
ligand with 0.375 Å spacing and coordinates of central
grid points of 121.253 Å, 121.376 Å, 120.149 Å, which
suit the protein cavity. The interaction for conventional
hydrogen bond (LYS 621, ASP 618, ASP 761, CYS 813,
GLU 811, SER 814), carbon-hydrogen bond (PRO 620,
ASP 618), pi-anion (ASP 760), and alkyl (LYS 798) were
found in the amino acid interaction with remdesivir, as
shown in Figure 2 and Supplementary Table S2.

Figure 2. Visualizing protein-ligand interactions of positive control (a) remdesivir and (b) favipiravir
E-ISSN 2477-0612
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This interaction of amino acids was also observed in
other studies on 6M71 RdRp, which referenced Gao
et al. (2020). The results showed that the residue ASP
618 found in Motif A active site protein is a classic
divalent-cation–binding residue. Jang et al. (2021) also
revealed that remdesivir-RdRp (ID: 6M71) binding
involved a significant contribution of ASP 618 amino
acid on hydrogen bonding. Another hydrogen interaction
was formed between remdesivir and the RdRp enzyme
6M71, namely LYS 621. This interaction was reported
in Eweas et al. (2021) and Gao et al. (2020)’s studies on
Motif A (fingers subdomain), where it appeared in the
prediction of the active site of 6M71. Jang et al., (2021)
and Pintilie et al., (2020) revealed that LYS 621 is one of
the framers of hydrogen interactions on 6M71 protein.
Furthermore, Gao et al. (2020) reported that PRO 620
is responsible for stabilizing the protein’s active site in
the palm subdomain, and its interaction with inhibitor
activity can destabilize protein expression. Other amino
acids of CYS 813, GLU 811, SER 814, and LYS 798
were found in a palm subdomain, which contributes to
the polymerase activity of the enzyme (Gao et al., 2020).
The critical amino acids that played a role in the primary
interaction of positive control-RdRp were also relevant
to other studies. This indicates that the grid box area
used contains several active amino acids, which play an
important role in the inhibitory activity of SARS-CoV-2
RdRp (6M71). Subsequently, a docking study of 19 A.
paniculata compounds to RdRp was carried out using
the validated grid box.
Evaluation of RdRp (6M71) Inhibitor Activity on
Chemical Constituents A. paniculata
Based on the docking results, some potential antiviral
drugs were detected against RdRp, which has the best
conformation with the lowest energy (most enormous
negative Gibbs’ free energy of binding (∆G) score),
as shown in Table 1. The top three docking scores of
bioactive A. Paniculata compound were ∆G = -8.86 kcal/
mol as the lowest binding energy of andrographolactone,
followed by andrographolide ∆G = -7.74 kcal/mol and
andrographidine-A ∆G = -7.68 kcal/mol. Furthermore,
these binding energies were lower compared to the
positive control of remdesivir and favipiravir, namely
-5.73 kcal/mol and -5.20 kcal/mol, respectively. The
high negative free energy of binding (∆G) scores indicate
the presence of spontaneous protein-ligand binding
that affects and stabilizes protein-ligand interaction.
They are also a better inhibitor of the molecular
docking prediction (Xing Du et al., 2016; Nusantoro
& Fadlan, 2021). The lowest binding score correlated
with the lowest inhibition constant (Ki) value. Based
on the results, the lowest Ki value was obtained from
andrographolactone, namely 321.37 nM (nanomolar),
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followed by andrographolide 2.10 uM (micromolar)
and andrographidine-A of 2.34 uM (micromolar). These
results indicate the concentration required to produce
a half-maximum inhibition value and show a stronger
ligand affinity for macromolecules (Yasin et al., 2020).
The docking results showed that andrographolactone can
stabilize and has a stronger affinity to bind to the active
side of RdRp (ID: 6M71) compared andrographolide and
andrographidine-A. This indicate that it has the potential
to be a candidate anti-SARS-CoV-2 drug by blocking
RdRp as a template anti-Genom of positive-sense RNA
to prevent viral replication (Ahmad et al., 2020).
The top three compounds, which had good binding
energy, namely andrographolactone, andrographolide
and andrographidine-A, were identified as terpenoids.
andrographolactone is another compound that showed
high binding energy with RdRp protein. Furthermore, it
is a novel diterpene with an unprecedented skeleton that
was isolated from the aerial part of A. paniculata (G. C.
Wang et al., 2009). Andrographolactone has the potential
to act as an anti-inflammatory agent by inhibiting TNF-a
(Firdayani & Srijanto, 2012), which can prevent cytokine
storms. This is the first study to show its activity as an
anti-SARS-CoV-2, specifically as a RdRp inhibitor.
Andrographolide is a bioactive and major constituent
in the leaves extract of A. paniculate, and it has antiinflammatory, antiviral, antitumor, and hepatoprotective
activities (Jayakumar et al., 2013). Sa-Ngiamsuntorn
et al. (2021) revealed that A. paniculata extract and
andrographolide have the same IC50 as remdesivir against
SARS-CoV-2 infection. This evidence can be used for
future antiviral development. Furthermore, previous
in-vitro studies on the anti-SARS-CoV-2 activity of A.
paniculata extract and andrographolide on Calu-3 cells
showed high inhibition at the late phases of the viral life
cycle including viral assembly and maturation with IC50
of 0.036 μg/mL and 0.034 μM. Another study using Vero
E6 cells reported that andrographolide had a stronger
effect compared to the extract. The chemical structure
of andrographolide and remdesivir have a common
functional group-containing naphthalene ring against
SARS-CoV-2 infection. Srikanth et al., (2021) showed a
very strong affinity of andrographolide to RdRp (6M71)
compared to RBD SARS-CoV-2, which indicates its
potential activity as a RdRp inhibitor. These compounds
have anti-inflammatory properties by inhibiting the
th1/th17 response and stabilizing cytokine expression.
Nie et al. (2017) showed that derivate andrographolide
can inhibit TNF-α/NF-κB and TLR4/NF-κB signaling
pathways to suppress cytokine pro-inflammation, and
this prevents the occurrence of cytokine storm that is
often observed in COVID-19 patients.
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Table 1. Binding energy values (docking score) of 19 A. Paniculata and positive control against
SARS-CoV-2 RdRp (ID: 6M71)
No

Ligands

Binding Energy (∆G)

Inhibition Constant (Ki)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Andrographolactone
Andrographolide
Andrographidine A
Andrographanine
Neoandrographolide
14-deoxy-11-oxoandrographolide
3-O-caffeoylquinic acid
Apigenin
12S-hydroxyandrographolide
14-deoxyandrographolide
Dehydroandrographolide
Deoxyandrographolide
5,2’-dihydroxy-7,8-dimethoxyflavanone
14-deoxy-17-hydroxyandrographolide
5,7-dihydroxy-8-methoxyflavone
Paniculide C
Caffeic acid
Paniculide B
Remdesivir
Cinaminic acid
Favipiravir

-8.86 kcal/mol
-7.74 kcal/mol
-7.68 kcal/mol
-7.58 kcal/mol
-7.55 kcal/mol
-7.54 kcal/mol
-7.29 kcal/mol
-7.13 kcal/mol
-7.08 kcal/mol
-7.04 kcal/mol
-6.98 kcal/mol
-6.95 kcal/mol
-6.79 kcal/mol
-6.77 kcal/mol
-6.77 kcal/mol
-6.42 kcal/mol
-6.42 kcal/mol
-6.15 kcal/mol
-5.73 kcal/mol
-5.72 kcal/mol
-5.20 kcal/mol

321.37 nM (nanomolar)
2.10 uM (micromolar)
2.34 uM (micromolar)
2.77 uM (micromolar)
2.94 uM (micromolar)
2.97 uM (micromolar)
4.53 uM (micromolar)
5.90 uM (micromolar)
6.44 uM (micromolar)
6.96 uM (micromolar)
7.66 uM (micromolar)
8.02 uM (micromolar)
10.61 uM (micromolar)
10.90 uM (micromolar)
10.95 uM (micromolar)
19.70 uM (micromolar)
19.75 uM (micromolar)
31.25 uM (micromolar)
62.84 uM (micromolar)
63.63 uM (micromolar)
155.21 uM (micromolar)

Swaminathan et al. (2021) revealed the potential
activity of A. paniculata phytocompounds against ten
structural and non-structural SARS-CoV-2 proteins
using molecular docking and dynamic simulation. The
result showed that andrographidine-A have good binding
energy with membrane protein, NSP15, and spike protein
of SARS-CoV-2. The limitation of these studies was that
there was no test on the RdRp target.
The top three compounds with the best docking score,
namely andrographolactone, andrographolide, and
andrographidine-A have relatively higher chemical
potential to cause increased reactivity compared to
remdesivir and favipiravir, which indicate that they
are a strong inhibitor of SARS-CoV-2 RdRp based on
molecular docking. They also have anti-SARS-CoV-2
potential based on previous wet and dry lab studies.
Analysis of Amino Acid Interaction
This study identified a critical amino acid that plays a role
in hydrogen interaction and active side of RdRp, such as
TYR 619, LYS 621, ASP 760, and ASP 623, as shown
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in Figure 3 and Supplementary Table S2. The hydrogen
bond is one of the non-covalent binders, which play a
significant role in the docking score, complex formation,
and strength binding modes (Fikrika et al., 2016).
Andrographolactone have strong binding energy to bind
with RdRp protein, and the amino acid interaction of the
compounds did not show hydrogen bond interaction.
However, it formed two pi-alkyl with ARG 349 and PRO
461 in finger domain RdRp, as shown in Figure 3a.
This study showed that TYR 619 had the highest number
of hydrogen bonds, namely 11, which contribute to the
second rank of docking compound andrographolide, as
shown in Figure 3b. Previous studies reported that it
also formed a hydrogen bond from remdesivir-RdRp
(ID: 6M71) complex using natural bioactive compounds
through molecular docking (Abd El-Aziz et al., 2021).
Eweas et al. (2021) showed that TYR 619 was present at
the predicted active site of the protein, which formed a
complex with remdesivir and hydroxychloroquine. TYR
619 (Y 619) is an essential amino acid in the active site
of Motif A RdRp (ID: 6M71) (Gao et al., 2020).
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Figure 3. Visualizing protein-ligand interactions of top three best docking scores
(a) andrographolactone, (b) andrographolide, and (c) andrographidine-A
LYS 621 in the active site also contributes to the formation
of three hydrogen interactions in andrographidine-A,
which was ranked third based on the docking score, as
shown in Figure 3c. This study’s results showed that the
amino acid have eight former hydrogen bonds. Previous
studies on remdesivir-RdRp (ID: 6M71) interaction
revealed that LYS 621 is one of the amino acids
responsible for the formation of hydrogen (Eweas et al.,
2021; Jang et al., 2021; Pintilie et al., 2020). Gao et al.
(2020) reported that it was present on Motif A (fingers
subdomain), and appeared in the prediction of the active
side of RdRp protein. The active amino acid residues of
ASP 760 and ASP 623 have 8 and 4 former hydrogen
bonds, respectively. This is comparable with previous
studies, such as Pintilie et al. (2020) which studied
remdesivir-RdRp (ID: 6M71), and revealed the presence
of the hydrogen interaction of ASP 760 or D760 and ASP
623. Pirzada et al., (2021) identified potential inhibitors
of RdRp (ID: 6M71) using FDA-approved antiviral
drugs, such as remdesivir, ledipasvir, and paritaprevir.
The results showed that ASP 760 and ASP 623 formed
the bonds in the catalytic binding site of RdRp and this
finding was strengthened by Gao et al., (2020).
This study’s result showed that the four amino acids
formed hydrogen bond that were responsible for the
energy binding score and they also stabilized the ligandprotein RdRp inhibition. The results of amino acid
interaction were comparable with the positive control–
bound protein complex. This finding showed that the
docking position of ligand on RdRp were ideal for the
active site containing enzyme catalytic area, which is
important for viral replication and transcription.

ADMET Prediction
The ADMET prediction of the top three A. paniculata
compounds using pkCSM is presented in Table 2, while
that of all compound is shown in Supplementary Table
S3 with parameters models from Pires et al., (2015). The
absorption prediction showed that andrographidine-A
had low permeability on Caco-2 cell, and the three
compounds showed good absorption on the intestine,
hence, they have the potential to be absorbed on the
intestinal membrane. However, andrographidine-A can
be considered in the design of drug delivery systems to
increase its ability to be well absorbed and penetrated,
which helps to obtain an ideal therapeutic bioavailability.
Andrographolactone have low skin permeability
compared to andrographidine-A and andrografolide,
indicating that it is bad for topical delivery design, but
can be used for oral delivery.
The distribution process of andrographidine-A
determined the prediction of Low VDss, which is poorly
distributed to the brain and unable to penetrate the CNS.
The compound can also have low lipophilicity to cross
the blood-brain barrier and central nervous system.
However, andrographolactone and andrografolide can
penetrate with high distribution in this high lipophilicity
area, and this helped to decrease the side effects and
toxicity or improve the pharmacological activity of
drugs.
Most of the metabolic reactions primarily found in the
liver are Cytochrome P450, which has some major
enzymes promoting prodrug activation or detoxification
by converting high polarity drug to excreted molecules.
E-ISSN 2477-0612

88

Pharm Sci Res, Vol 9 No 2, 2022

Ahsana, et al.

Table 2. ADMET prediction of top three docking score A. paniculata compounds using pkCSM online server
Process

Models

Unit

Absorption

Caco-2 cell permeability
Intestinal absorption (human)
Skin permeability
VDss (human)
BBB permeability
CNS permeability
CYP2D6 substrate
CYP3A4 substrate
CYP1A2 inhibitor
CYP2C19 inhibitor
CYP2C9 inhibitor
CYP2D6 inhibitor
CYP3A4 inhibitor
Total clearance
Renal OCT2 substrate
AMES toxicity
hERG I inhibitor
hERG II inhibitor
Hepatotoxicity
Skin sensitisation
T. pyriformis toxicity
Minnow toxicity

Numeric (log Papp in 10-6 cm/s)
Numeric (% Absorbed)
Numeric (log Kp)
Numeric (log L/kg)
Numeric (log BB)
Numeric (log PS)
Categorical (Yes/No)

Distribution

Metabolism

Excretion
Toxicity

E-ISSN 2477-0612

Numeric (log ml/min/kg)
Categorical (Yes/No)
Categorical (Yes/No)

Numeric (log ug/L)
Numeric (log mM)

Compounds
Andrographolactone

Andrographolide

Andrographidine A

1.798
96.48
-2.229
0.818
0.239
-2.223
No
Yes
Yes
Yes
No
No
No
1.288
No
No
No
No
No
Yes
2.611
-0.35

1.075
92.432
-3.539
-0.097
-0.615
-2.629
No
Yes
No
No
No
No
No
1.179
No
No
No
No
Yes
No
0.636
1.155

0.379
67.146
-2.736
-0.659
-1.35
-4.023
No
No
No
No
No
No
No
0.74
No
No
No
No
No
No
0.285
4.074
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The results showed that andrographolactone and
andrografolide were predicted as substrate of the CYP3A4
enzyme. They are easy to metabolize and excrete from
the body to prevent toxicity. Cytochrome P450 3A4
(CYP3A4) is the major cytochrome because CYP3A4
can metabolize most types of drug. The prediction results
revealed that andrographolactone can serve as a CYP3A4
substrate, CYP1A2 inhibitor, and CYP2C19 inhibitor.
Based on the excretion prediction, andrographolactone,
andrographolide, and andrographidine-A are not renal
OTC2 substrate that cause interactions when administered
concurrently with OCT2 Inhibitors. The result of toxicity
prediction shows that these compound do not indicate the
mutagenicity on AMES toxicity prediction and hERG
inhibitor, which can lead to heart problems. Based on
T.Pyriformis toxicity, all compounds can cause toxicity
to the protozoan. The hepatotoxicity test revealed that
andrographolactone and andrographidine-A are not toxic,
while the Skin Sensitisation prediction showed that
andrographolactone have an effect on the skin.
The ADMET prediction using the pkCSM of the top three
docking scores showed that andrographolactone have
more good values in ADMET studies. This result can be
proved by comparing in-vitro and in-vivo studies.
CONCLUSION
The results showed the lower binding energy (∆G)
of the top three bioactive A. paniculata compounds,
namely andrographolactone, andrographolide, and
andrographidine-A, respectively, which can be prevented
by the replication, transcription, and synthesis of
SARS-CoV-2 RdRP (ID: 6M71) were creates hydrogen
interaction with TYR 619, LYS 621, ASP 760, and ASP
623. TYR 619, LYS 621, ASP 760, and ASP 623. The
ADMET prediction revealed that andrographolactone has
low toxicity, which is ideal for an orally active drug for
humans. However, there is a need for further studies on
andrographolactone as a novel therapeutic candidate by
Molecular Dynamic or QSAR, followed by pre-clinical
in-vitro and in-vivo SARS-CoV-2 studies.
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